DCP Board Change Neutral
DIS-CHEM PHARMACIES LIMITED - Directorate Change
Dis-Chem Pharmacies Limited
Free preview
What this filing means
Dis-Chem has notified shareholders of the resignation of Mr Saul Saltzman as Non-Executive Director, effective 17 July 2026, in compliance with JSE Listings Requirements. No new financial, operational or strategic information is contained in the filing — it is a routine governance disclosure.
Bear case
- No new economic information about Dis-Chem's business, earnings, or strategy — a director resignation is a governance event, not an investment signal.
View original SENS announcement
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
Unlock the full analysis
Free during launch. Sign in to read the complete breakdown.
- Full bull / bear breakdown
- Decision framework
- Citations & sources
- Price autopsy
More on Dis-Chem Pharmacies Limited
Related filings
More from DCP
- DIS-CHEM PHARMACIES LIMITED - Results of Annual General Meeting
- DIS-CHEM PHARMACIES LIMITED - Directorate Change
- DIS-CHEM PHARMACIES LIMITED - Dealings in Securities
- DIS-CHEM PHARMACIES LIMITED - Dealings in Securities
- DIS-CHEM PHARMACIES LIMITED - Distribution of Integrated Annual Report; Notice of Annual General Meeting; and B-BBEE Annual Compliance Report
Other Board Change
- OPAOPTASIA LIMITED - Change to the Board and Board Committee
- RBXRAUBEX GROUP LIMITED - Early Retirement of Chief Operating Officer and Appointment of New Chief Operating Officer
- AIRPORTS COMPANY SOUTH AFRICA SOC LIMITED - APPOINTMENTS AND CHANGES TO BOARD COMMITTEES
- APHALPHAMIN RESOURCES CORPORATION - Alphamin Announces Appointment of Director/ Files Q2 2026 Financial Statements and MD&A
- AXXARAXI LIMITED - Notice of Board Retirement, Appointment of Non-Executive Directors and Change in Role of Director